AN2 Therapeutics, Inc. 8-K

Accession 0001193125-24-202430

Filing information

CIK: 0001880438
Report date: 2024-08-15
Filing date: 2024-08-19
Form: 8-K
Primary document: d879523d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.